Pfizer sues Metsera, Novo Nordisk
Digest more
Novo Nordisk cuts over 800 jobs in Plainsboro, part of a global restructuring under the new CEO, reflecting a troubling trend ...
The chairman of Novo Nordisk and six other independent board members quit on Tuesday after a dispute with the company's ...
Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.
Novo Nordisk layoffs: Denmark-based pharmaceuticals major, Novo Nordisk's Chief Executive Officer (CEO) Mike Doustdar, on ...
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s unsolicited proposal to acquire Metsera, renewed legal action against Tylenol’s manufacturer following statements from Robert F.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback